Close Menu

NEW YORK (GenomeWeb) – Twist Bioscience and Desktop Genetics today announced that they have formed a partnership to develop and offer integrated experiment design and DNA synthesis tools to facilitate gene-editing research. 

Under the terms of the deal, Desktop will collaborate with its customers to computationally design sgRNA libraries for CRISPR applications in any cell line. These libraries will then be synthesized by Twist and shipped directly to customers.

Additional terms of the arrangement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.